A 42-year-old female presented with an 8-week history of progressive generalized rash and mucocutaneous ulcers associated with 50-pound weight loss. She had no personal or family history of autoimmune disease. No recent illness or change in medications before the onset of her rash.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to The American Journal of Medicine
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Paraneoplastic pemphigus: insight into the autoimmune pathogenesis, clinical features and therapy.Int J Mol Sci. 2017; 18: 2532https://doi.org/10.3390/ijms18122532
- Paraneoplastic pemphigus: paraneoplastic autoimmune disease of the skin and mucosa.Front Immunol. 2019; 10: 1259https://doi.org/10.3389/fimmu.2019.01259
- Laboratory diagnosis of paraneoplastic pemphigus.Br J Dermatol. 2013; 169: 1016-1024https://doi.org/10.1111/bjd.12479
- Current management strategies in paraneoplastic pemphigus (paraneoplastic autoimmune multiorgan syndrome).Dermatol Clin. 2011; 29: 607-612https://doi.org/10.1016/j.det.2011.06.016
- Paraneoplastic pemphigus associated with b-cell chronic lymphocytic leukemia treated with ibrutinib and rituximab.Intern Med. 2018; 57: 2395-2398https://doi.org/10.2169/internalmedicine.0578-17
Published online: February 20, 2021Thomas J. Marrie, MD, Section Editor
Conflicts of Interest: None.
Authorship: All authors had access to the data and a role in writing this manuscript.
© 2021 Elsevier Inc. All rights reserved.